Literature DB >> 7005263

Complement-mediated defect in clearance and sequestration of sensitized, autologous erythrocytes in rodent malaria.

M G Pappas, R S Nussenzweig, V Nussenzweig, H L Shear.   

Abstract

We investigated the ability of malaria-infected and normal mice to clear particulate immune complexes consisting of autologous erythrocytes sensitized with either IgG or complement. Normal mice rapidly clear autologous erythrocytes optimally sensitized with IgG and the liver plays a major role in their sequestration. Clearance of optimally sensitized erythrocytes is complement-dependent because cobra venom factor-treated, normal mice failed to clear these cells rapidly, unless they had been pre-treated with fresh mouse serum. In the initial phase of Plasmodium berghei infection, clearance of the optimally sensitized erythrocytes was markedly increased over that observed in normal mice. 2 wk after infection, however, clearance was minimal. This defect was most likely the consequence of the hypocomplementemia observed at this stage of infection since sensitized erythrocytes were removed rapidly from the blood if they had been coated with C3 in vitro before injection into malarial mice.The functional activity of the complement receptors of phagocytic cells was assayed in malarial mice by the injection of autologous erythrocytes coated with C3 and C4 in the absence of antibody. The complement-coated erythrocytes were rapidly removed from the blood, accumulated in the liver, and then gradually returned to the circulation. Similar patterns were observed in normal animals, but the degree of clearance was considerably higher in the malarial mice late in infection. It appears, therefore, that complement receptors remain functional throughout the infection. Erythrocytes suboptimally sensitized with IgG were cleared minimally by normal mice. This clearance was not complement-dependent and was mediated mainly by the spleen. During malaria, clearance of these particles was initially enhanced but later it was abolished.The association of hypocomplementemia with a major splenic defect in clearance late in malaria infection may explain the accumulation of immune complexes in pathological sites observed in this disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7005263      PMCID: PMC371586          DOI: 10.1172/JCI110011

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

Review 2.  NIH conference. Pathophysiology of immune hemolytic anemia.

Authors: 
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

Review 3.  Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.

Authors:  M Takahashi; J Czop; A Ferreira; V Nussenzweig
Journal:  Transplant Rev       Date:  1976

4.  The "sugar-water" test for paroxysmal nocturnal hemoglobinuria.

Authors:  R C Hartmann; D E Jenkins
Journal:  N Engl J Med       Date:  1966-07-21       Impact factor: 91.245

5.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

6.  Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity.

Authors:  C A Facer; R S Bray; J Brown
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

7.  Mouse C4 (Ss): three-step purification of its C4c fragment and production of a monospecific antiserum.

Authors:  A Ferreira; V Nussenzweig
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

8.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

9.  The fine structure of Plasmodium falciparum and its host erythrocytes in natural malarial infections in man.

Authors:  W Trager; M A Rudzinska; P C Bradbury
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

10.  A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.

Authors:  C Bianco; R Patrick; V Nussenzweig
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Factors influencing immune complex localisation.

Authors:  L Schrieber; R Penny
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

2.  Variation in expression of antibody-dependent cell-mediated cytotoxicity in rodents with malaria.

Authors:  H L Shear
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

3.  Imaging and assessment of regional clearances of indium-111 labelled circulating immune complexes in humans.

Authors:  E Wirquin; C Bruneau; M Meignan; L Cinotti; A Sobel
Journal:  Eur J Nucl Med       Date:  1986

4.  Murine malaria: immune complexes inhibit Fc receptor-mediated phagocytosis.

Authors:  H L Shear
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Interactions of killed Listeria monocytogenes with the mouse complement system.

Authors:  K P van Kessel; A C Antonissen; H van Dijk; P M Rademaker; J M Willers
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

6.  Malaria-induced lymphokines: stimulation of macrophages for enhanced phagocytosis.

Authors:  C F Ockenhouse; H L Shear
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

7.  Macrophage plasma membrane and secretory properties in murine malaria. Effects of Plasmodium yoelii blood-stage infection on macrophages in liver, spleen, and blood.

Authors:  S H Lee; P Crocker; S Gordon
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.